Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Drug Toxicity: Risk factors

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Factors Affecting Illness

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Factors Affecting Protein-Drug Binding: Drug Interactions

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Access in all areas? A round-up of developments in market access and health technology assessment: part 15.

Journal of comparative effectiveness research·2026

Same author

Most-Favored-Nation pricing meets Joint Clinical Assessment: early evidence of compounding pressure on European drug launches.

Journal of comparative effectiveness research·2026

Same author

Access in all areas? A round-up of developments in market access and health technology assessment: first Joint Clinical Assessment report released.

Journal of comparative effectiveness research·2026

Same author

Comparison between ELISA and SIMOA assay for detection of serum neurofilament light chain in post-anoxic encephalopathy.

Journal of neuroscience methods·2026

Same author

R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 26.

Journal of comparative effectiveness research·2026

Same author

R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25.

Journal of comparative effectiveness research·2026

Same journal

Role of Cholesterol Metabolism in the Link Between Diabetes and Alzheimer's Disease.

CNS & neurological disorders drug targets·2026

Same journal

Linking Neurodegeneration and Age-related Macular Degeneration: Unified Pathways and Intervention Strategies.

CNS & neurological disorders drug targets·2026

Same journal

Modulating the Microbiota-gut-brain Axis: A Promising Strategy for Alzheimer's Disease Prevention and Management.

CNS & neurological disorders drug targets·2026

Same journal

The Therapeutic Effects of Dietary Supplements on OCD: A Narrative Review.

CNS & neurological disorders drug targets·2026

Same journal

Amyotrophic Lateral Sclerosis: Therapeutic Innovations and Evolving Regulatory Approaches.

CNS & neurological disorders drug targets·2026

Same journal

Pathogenic Proteins Driving ALS Pathogenesis: Molecular Mechanisms and Translational Therapeutic Perspectives.

CNS & neurological disorders drug targets·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 22, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Modeling Multiple Sclerosis in the Two Sexes: MOG_35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Multiple sclerosis: risk factors and their interactions.

Giulio Disanto¹, Julia M Morahan, Sreeram V Ramagopalan

¹Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Headington, Oxford, UK.

CNS & Neurological Disorders Drug Targets

|May 16, 2012

Summary

This summary is machine-generated.

Multiple sclerosis (MS) risk is influenced by genetic and environmental factors like vitamin D deficiency and smoking. Understanding these interactions is key to developing prevention strategies for this immune-mediated disorder.

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Related Experiment Videos

Last Updated: May 22, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Modeling Multiple Sclerosis in the Two Sexes: MOG_35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Area of Science:

Neuroimmunology
Epidemiology of Central Nervous System Disorders

Background:

Multiple sclerosis (MS) is a significant immune-mediated central nervous system disorder with substantial global health and economic impact.
Despite advances, the precise risk factors and their contribution to MS pathogenesis remain incompletely understood.
Current research indicates MS arises from a complex interplay between genetic predisposition and environmental exposures throughout life.

Purpose of the Study:

To elucidate the implicated risk factors in multiple sclerosis (MS) pathogenesis.
To understand how genetic susceptibility and environmental exposures interact to influence MS development.
To identify potential targets for MS prevention strategies.

Main Methods:

Review of existing epidemiological and genetic studies on multiple sclerosis (MS).
Analysis of the synergistic and multiplicative effects of identified risk factors.
Synthesis of evidence linking environmental exposures to genetic predisposition.

Main Results:

Key environmental factors implicated in MS include vitamin D deficiency, season of birth, Epstein Barr virus infection, and smoking.
These factors interact synergistically with genetic susceptibility.
The combined risk of MS increases multiplicatively with exposure to multiple risk factors.

Conclusions:

A significant portion of multiple sclerosis (MS) cases may be preventable.
Understanding the timing and interplay of risk factor exposure is crucial for developing effective prevention strategies.
Further research into the mechanisms of synergistic risk factor interaction is warranted.